Xigduo XR 5 mg / 500 mg, Filmtabletten - 98 Tablette(n) Swissmedic Key 65377002 PP Registration Holder AstraZeneca AG Name Xigduo XR 5 mg / 500 mg, Filmtabletten Date of registration 16.07.2015 Introduction of Sequence 16.07.2015 ATC-Classification Metformin and Dapagliflozin (A10BD15) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.06.20. Show package size 98 Tablette(n) Index Therapeuticus (Swissmedic) 07.06.20. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 83.56 Limitation Yes Limitation text
Deductible 10 % Consumer price 107.30 Feedback FB GTIN 7680653770029 Medication Code Synthetika Pharmacode 6457479 Disponibility
Composition metformini hydrochloridum 500 mg, dapagliflozinum 5 mg ut dapagliflozinum propandiolum monohydricum, carmellosum natricum corresp. natrium 4.77 mg, hypromellosum, cellulosum microcristallinum, silica colloidalis hydrica, magnesii stearas, lactosum 48.00 mg, crospovidonum, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, E 110 0.69 mg, E 171, pro compresso obducto. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Dapagliflozinum 5 mg Metformin Hydrochloride 500 mg
BAG: Active Agent Dose Dapagliflozinum 5 mg Metformin Hydrochloride 500 mg
Inactive agents Dose additional_information Carmellose Sodium Cellulosum Microcristallinum Crospovidonum E 110 0.69 mg color. E 171 color. Hypromellosum Lactosum 48 mg Macrogol 3350 Magnesii Stearas Poly(Alcohol Vinylicus) Überzug Pro Compresso Obducto Silica Colloidalis Hydrica Talcum
Source Data was imported : 04.06.2020
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
